BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Toxikon Expands Analytical Chemistry Services


10/19/2005 5:12:46 PM

BEDFORD, Mass., Feb. 17 /PRNewswire/ -- Toxikon Corporation, a life science testing and consulting firm, announced today that it has completed the consolidation and expansion of its chemistry services for pharmaceutical, medical device, and environmental testing.

"Chemistry, an essential component of our services, has been upgraded to meet the ongoing needs of our key business areas," said Dr. Laxman Desai, CEO. "Consolidating our extensive analytical chemistry capabilities to our new, expanded facilities in Bedford also gives us greater capacity for general and specialty chemistry for ISO 10993, Part 18 for leachables and extractables and other medical device testing," he explained. Dr. Desai also noted that environmental chemistry services remain a growing and vital part of the overall analytical services division.

The company also reported that as part of the expansion bioanalytics services have been added to serve the drug development needs of biotech and pharmaceutical companies in preclinical and clinical studies. Toxikon provides method development and validation as well as high-throughput sample analysis for its clients to support them through drug discovery, preclinical, and clinical studies as well as manufacturing analysis to meet regulatory compliance.

Founded in 1977, Toxikon is a privately owned contract research organization providing toxicology, pharmacology, in-vitro and analytical testing services for companies, research institutions, and government agencies, worldwide. Focused on preclinical and other early stage product and process development, Toxikon helps to assure safety, regulatory compliance, and speed-to-market for clients in biotech, pharmaceuticals, medical device, and chemical industries. Toxikon also provides manufacturing support and test related services post approval.

Toxikon is headquartered in Bedford, MA, and operates testing and laboratory facilities at this location and in Belgium.

Contacts: Laxman Desai 781-275-3330 x104 laxman.desai@toxikon.com Larry Miller 781-275-3330 x121 larry.miller@toxikon.com Ted Agne 781-631-3117 edagne@comstratgroup.com

Toxikon Corporation

CONTACT: Laxman Desai, +1-781-275-3330, ext. 104,laxman.desai@toxikon.com, or Larry Miller, +1-781-275-3330, ext. 121,larry.miller@toxikon.com, both of Toxikon; or Ted Agne, +1-781-631-3117,edagne@comstratgroup.com of Communications Strategy Group



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES